Advanced search    

Search: authors:"Margherita Canesi"

6 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Erratum to: Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study

-year retrospective case–control study”, written by Emanuele Cereda, Roberto Cilia, Margherita Canesi, Silvana Tesei, Claudio Bruno Mariani, Anna Lena Zecchinelli and Gianni Pezzoli, was originally

Factors influencing psychological well-being in patients with Parkinson’s disease

, Alessandro Tessitore, Margherita Canesi, Mario Zappia. Formal analysis: Alessandra Nicoletti, Giovanni Mostile, Mario Zappia. Investigation: Alessandra Nicoletti, Fabrizio Stocchi, Giovanni Abbruzzese ... , Roberto Ceravolo, Pietro Cortelli, Marco D'Amelio, Maria F. De Pandis, Giovanni Fabbrini, Claudio Pacchetti, Gianni Pezzoli, Alessandro Tessitore, Margherita Canesi, Mario Zappia. Methodology: Alessandra

Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments

Background to date, there are no medical or surgical treatments for progressive supranuclear palsy (PSP). It is possible to speculate that patients with PSP could benefit from rehabilitative treatments designed for Parkinson’s disease, including the use of robot-assisted walking training. Objective to evaluate whether the use of the robotic device Lokomat® is superior in PSP...

Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy

Background The trophic, anti-apoptotic and regenerative effects of bone marrow mesenchymal stromal cells (MSC) may reduce neuronal cell loss in neurodegenerative disorders. Methods We used MSC as a novel candidate therapeutic tool in a pilot phase-I study for patients affected by progressive supranuclear palsy (PSP), a rare, severe and no-option form of Parkinsonism. Five...

Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study

Background Progressive Supranuclear Palsy (PSP) is a sporadic and progressive neurodegenerative disease which belongs to the family of tauopathies and involves both cortical and subcortical structures. No effective therapy is to date available. Methods/design Autologous bone marrow (BM) mesenchymal stem cells (MSC) from patients affected by different type of parkinsonisms have...